These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6502606)

  • 1. Tetrahydropyrrolo[1,2-a]quinoxalines and tetrahydropyrrolo[1,2-a]pyrido[3,2-a]pyrazines: vascular smooth muscle relaxants and antihypertensive agents.
    Abou-Gharbia M; Freed ME; McCaully RJ; Silver PJ; Wendt RL
    J Med Chem; 1984 Dec; 27(12):1743-6. PubMed ID: 6502606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
    Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C
    J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octahydropyrazino[2',3':3,4]pyrido[1,2-a]indoles. A new class of potent antihypertensive agents.
    Jirkovsky I; Santroch G; Baudy R; Oshiro G
    J Med Chem; 1987 Feb; 30(2):388-94. PubMed ID: 3806618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives.
    Ohtake Y; Naito A; Hasegawa H; Kawano K; Morizono D; Taniguchi M; Tanaka Y; Matsukawa H; Naito K; Oguma T; Ezure Y; Tsuriya Y
    Bioorg Med Chem; 1999 Jun; 7(6):1247-54. PubMed ID: 10428398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines.
    Saxena AK; Rao J; Chakrabarty R; Saxena M; Srimal RC
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1708-12. PubMed ID: 17234413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of pyrido quinoxalines as new family of antimalarial agents.
    Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS
    Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel routes to 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines and 5,6,9,10,11,11a-hexahydro-8H-pyrido[1,2-a]pyrrolo[2,1-c]pyrazines.
    Katritzky AR; Jain R; Xu YJ; Steel PJ
    J Org Chem; 2002 Nov; 67(23):8220-3. PubMed ID: 12423155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity.
    Parra S; Laurent F; Subra G; Deleuze-Masquefa C; Benezech V; Fabreguettes J; Vidal J; Pocock T; Elliott K; Small R; Escale R; Michel A; Chapat J; Bonnet P
    Eur J Med Chem; 2001 Mar; 36(3):255-64. PubMed ID: 11337104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of substituted [1]benzothieno[2,3-b]pyrazines and their ability to antagonize KCl induced contractions.
    Guerrera F; Salerno L; Sarvà MC; Siracusa MA; Rescifina A; Scalia R; Bianchi A
    Farmaco; 1994; 49(7-8):467-73. PubMed ID: 7945711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines.
    Welmaker GS; Nelson JA; Sabalski JE; Sabb AL; Potoski JR; Graziano D; Kagan M; Coupet J; Dunlop J; Mazandarani H; Rosenzweig-Lipson S; Sukoff S; Zhang Y
    Bioorg Med Chem Lett; 2000 Sep; 10(17):1991-4. PubMed ID: 10987434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonists.
    Richter HG; Adams DR; Benardeau A; Bickerdike MJ; Bentley JM; Blench TJ; Cliffe IA; Dourish C; Hebeisen P; Kennett GA; Knight AR; Malcolm CS; Mattei P; Misra A; Mizrahi J; Monck NJ; Plancher JM; Roever S; Roffey JR; Taylor S; Vickers SP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1207-11. PubMed ID: 16361098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on compounds with antiblastic activity. XXXIX. Potentially carcinogenic polycyclic nitrogen compounds related to azasteroids. Synthesis of pyrido-(3,2-f)-pyrrolo-(1,2-a)-quinoxaline and its 4-substituted derivatives.
    Artico M; Giuliano R; Vomero S
    Farmaco Sci; 1970 May; 25(5):331-40. PubMed ID: 5451637
    [No Abstract]   [Full Text] [Related]  

  • 13. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of pyrido[2,3-e]pyrrolo[1,2-a]pyrazine derivatives via tandem iminium cyclization and smiles rearrangement.
    Xiang J; Xie H; Wen D; Dang Q; Bai X
    J Org Chem; 2008 Apr; 73(8):3281-3. PubMed ID: 18355079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates.
    Temple C; Rener GA
    J Med Chem; 1990 Nov; 33(11):3044-50. PubMed ID: 2231603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Substituted 5-chloro-1,3-dihydro-2H-imidazo(4,5-b)pyrazin-2-ones with hypotensive activity.
    Jones JH; Holtz WJ; Cragoe EJ
    J Med Chem; 1973 May; 16(5):537-42. PubMed ID: 4352334
    [No Abstract]   [Full Text] [Related]  

  • 17. Wy-46,300 and Wy-46,531: vascular smooth muscle relaxant/antihypertensive agents with combined Ca2+ antagonist/myosin phosphorylation inhibitory mechanisms.
    Silver PJ; Sulkowski TS; Lappe RW; Wendt RL
    J Cardiovasc Pharmacol; 1986; 8(6):1168-75. PubMed ID: 2434743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator and antihypertensive actions of 3-nitropropionic acid.
    Hong E; Castillo C; Rivero I; Somanathan R
    Proc West Pharmacol Soc; 1990; 33():209-11. PubMed ID: 2125725
    [No Abstract]   [Full Text] [Related]  

  • 19. A possible mechanism of action of tetramethylpyrazine on vascular smooth muscle in rat aorta.
    Wu CC; Chiou WF; Yen MH
    Eur J Pharmacol; 1989 Oct; 169(2-3):189-95. PubMed ID: 2553446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery.
    Shan Au AL; Kwan YW; Kwok CC; Zhang RZ; He GW
    Eur J Pharmacol; 2003 May; 468(3):199-207. PubMed ID: 12754058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.